Programmable nanomotor system responsively and chemotactically captures tumor associated antigens for enhanced <i>in situ</i> cancer vaccine. [PDF]
Song P +6 more
europepmc +1 more source
ABSTRACT All cases of invasive cervical cancer (ICC) and subsets of high‐grade cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) and adenocarcinoma in situ (AIS) in Norway are tested for 37 human papillomavirus (HPV) genotypes, within a mandatory national surveillance system.
Terese Bekkevold +13 more
wiley +1 more source
Enhancing DC cancer vaccine by allogeneic MHC class II expression and Treg depletion. [PDF]
Seishima N +6 more
europepmc +1 more source
Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platforms. [PDF]
Pazoki A +4 more
europepmc +1 more source
A Nanomodulator Enhances Radiotherapy-Induced In Situ Cancer Vaccine by Promoting Antigen-Presenting of Tumor-Associated Macrophage. [PDF]
Zhao X +9 more
europepmc +1 more source
Human Papillomavirus-Related Cancer Vaccine Strategies. [PDF]
Cai X, Xu L.
europepmc +1 more source
Balancing Antigen Loading on Gold Nanoparticles: Implications for Future Cancer Vaccine Strategies. [PDF]
Ghirardello M +8 more
europepmc +1 more source
Promising future of breast cancer vaccine asking for multidisciplinary collaboration: a literature review. [PDF]
Zhang Z +8 more
europepmc +1 more source
Related searches:
Why Young Patients With Cancer Refuse the Human Papillomavirus Vaccine
Ca-A Cancer Journal for Clinicians, 2023Mike Fillon
exaly

